Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland

11. Literatur 210
with breast cancer and 100,239 women without breast cancer from 54 epidemiological
studies. Lancet 1996;347:1713–27.
101. Collaborative Group on Hormonal Factors in Breast cancer. Breast cancer and
hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological
studies of 52,705 women with breast cancer and 108,411 women without
breast cancer. Lancet 1997;350:1047–59.
102. Committee on Quality Assurance in Mammography W. Guidelines of the American
College of Radiology. 1999.
103. Council of Europe (Hrsg). Developing a methodology for drawing up guidelines on
best medical practice. Recommendation Rec (2001)13 adopted by the Committee of
Ministers of the Council of Europe on 10 october 2001 and explanatory memorandum.
Strasbourg Cedex: Council of Europe Publishing, 2002.
104. Council of Europe. Recommendation NO. R (97) 17 on the development and
implementation of quality improvement systems (QIS) in health care. Strasbourg:
Council of Europe, 1997.
105. Cretin S. Putting clinical guidelines into practice in: Margolis CZ, (1999). In: Cretin S.
Implementing clinical practice guidelines. Chicago: AHA Press.
106. Damascelli B, Frigerio LF, Lanocita R, Patelli G, et al. Stereotactic excisional breast
biopsy performed by interventional radiologists using the advanced breast biopsy
instrumentation system. Br J Radiol 1998;71:1003–111.
107. Decker T, Ruhnke M, Schneider W. Standardized pathologic examination of breast
excision specimen. Relevance within an interdisciplinary practice protocol for quality
management of breast saving therapy. Pathologe 1997;18:53–9.
108. Delbecq AL, Van de Ven AH, Gustafson DH. Group Techniques for Program Planning:
A Guide to Nominal Group and Delphi Processes. Scott, Foresman and Company, USA
1975.
109. Dempsey P, Rubin E. The roles of needle biopsy and periodic follow-up in the evaluation
and diagnosis of breast lesions. Semin Roentgenol 1993;28:252–8.
110. Dent DM, Kirkpatrick AE, Mc Googan E, Chetty U, Anderson TJ. Stereotaxic
localization and aspiration cytology of impalpable breast lesions. Clin Radiol
1989;40:380–2.
111. Denton ER, Field S. Just how valuable is double reporting in screening mammography?
Clin Radiol 1997;52:466–8.
112. Department of Health Medical Devices Directorate. Evaluation of specimen radiography
cabinets: reports and guidance notes. Blue book (MDD/91/ 13) London:
Department of Health 1991;1–33.
113. Dershaw D, Eddens G, Liberman L, Deutch BM, Abramson AF. Sonographic and
clinical findings in women with palpable breast disease and negative mammography.
Breast Dis 1995;8:13.
114. Desch CE, Benson AB, Smith PJ, et al. Recommended colorectal cancer surveillance
guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999;17:1312.
115. Deutsche Krebsgesellschaft. Koordination: Informationszentrum für klinische Studien
(ISTO), in Qualitätssicherung in der Onkologie-Diagnose und Therapie maligner
Erkrankungen – Kurzgefasste interdisziplinäre Leitlinien. edited by Hermanek P,
München Bern Wien New York, Zuckschwerdt Verlag 2000;124–63.
116. Deutsche Röntgengesellschaft. Empfehlungen des Ausschusses Magnetresonanzmammographie
für Qualitätsanforderungen der MRT der Mamma. Jahresbericht
1995;43:59–61.
117. Deutsche Röntgengesellschaft. Empfehlungen der DRG: Leitlinien Mammadiagnostik,
Leitlinie Mammaintervention. 2002.
118. Dey I. Qualitative research. A user-friendly guide for social scientists. Routledge,
London, NewYork. 1993.